Refine Search
(0)
(11)
(39)
(76)

Polycythemia Vera - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2019’, provides an overview of the Polycythemia Vera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Polycythem...

Fibrosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrosarcoma - Pipeline Review, H1 2019’, provides an overview of the Fibrosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrosarcoma, comple...

Osteosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2019’, provides an overview of the Osteosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteosarcoma, comple...

Nasopharyngeal Cancer - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2019’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Na...

Synovial Sarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Synovial Sarcoma - Pipeline Review, H1 2019’, provides an overview of the Synovial Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Synovial Sar...

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

The report provides comprehensive information on...

Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2019’, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline landscape.

The report provides comprehensive information ...

Rectal Cancer - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2019’, provides an overview of the Rectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rectal Cancer, com...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

The report provides comprehensive information on the therapeut...

Anal Cancer - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2019’, provides an overview of the Anal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete ...

Leiomyosarcoma - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Leiomyosarcoma - Pipeline Review, H1 2019’, provides an overview of the Leiomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Leiomyosarcoma, ...

Cervical Cancer - Pipeline Review, H2 2018

  • $2,000
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H2 2018’, provides an overview of the Cervical Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cervical Cance...

Melanoma - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Melanoma - Pipeline Review, H2 2018’, provides an overview of the Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Melanoma, complete with anal...

Pancreatic Cancer - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H2 2018’, provides an overview of the Pancreatic Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pancreatic...

Colorectal Cancer - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H2 2018’, provides an overview of the Colorectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colorectal...

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape.

The report provides comprehensive informatio...

Head And Neck Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H2 2018’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head...

Gastric Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2018’, provides an overview of the Gastric Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastric Cancer, ...

Bone Metastasis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H2 2018’, provides an overview of the Bone Metastasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Metastasi...

Fallopian Tube Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2018’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fa...

Oropharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oropharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Oropharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Orop...

Peritoneal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H2 2018’, provides an overview of the Peritoneal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritoneal...

Pheochromocytoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pheochromocytoma - Pipeline Review, H2 2018’, provides an overview of the Pheochromocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pheochromocy...

Essential Thrombocythemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H2 2018’, provides an overview of the Essential Thrombocythemia pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018’, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) pipeline landscape.

The report provides comprehensive informat...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape.

The report provides comprehensive in...

Retinoblastoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H2 2018’, provides an overview of the Retinoblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinoblastoma, ...

Rhabdomyosarcoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2018’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rhabdomyosar...

Hairy Cell Leukemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2018’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hairy ...

Ureter Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H2 2018’, provides an overview of the Ureter Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ureter Cancer, com...

Uveal Melanoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H2 2018’, provides an overview of the Uveal Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, ...

Oligodendroglioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2018’, provides an overview of the Oligodendroglioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Oligodendr...

Thyroid Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thyroid Cancer - Pipeline Review, H2 2018’, provides an overview of the Thyroid Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thyroid Cancer, ...

Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018’, provides an overview of the Cancer Anorexia-Cachexia Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Esophageal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2018’, provides an overview of the Esophageal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Esophageal...

Malignant Mesothelioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2018’, provides an overview of the Malignant Mesothelioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Ependymoma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ependymoma - Pipeline Review, H2 2018’, provides an overview of the Ependymoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ependymoma, complete wit...

Hypopharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypopharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Hypopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hy...

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018’, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline landscape.

The report provides comprehensive informat...

Ovarian Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2018’, provides an overview of the Ovarian Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, ...

Prostate Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2018’, provides an overview of the Prostate Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Prostate Cance...

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

The report p...

Colon Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2018’, provides an overview of the Colon Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colon Cancer, comple...

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2018’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

The report provides comprehensive information on the therap...

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under dev...

Medulloblastoma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2018’, provides an overview of the Medulloblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Medulloblastom...

Recurrent Malignant Glioma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2018’, provides an overview of the Recurrent Malignant Glioma pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...